(E/Z)-BML264

(E/Z)-BML264 is an inhibitor of Phospholipases and Lipases and related targets used in studies of Calcium Signaling and Metabolic Signaling. It is especially relevant in cell signaling, inflammation, and metabolism models, where defined compound exposure can be linked to calcium flux, excitability, and secretion-linked signaling and metabolic regulation, energy sensing, and enzyme-linked homeostasis.

By inhibiting Phospholipases and Lipases and related targets, (E/Z)-BML264 can be used to examine calcium flux, excitability, and secretion-linked signaling and metabolic regulation, energy sensing, and enzyme-linked homeostasis. The enzyme annotation adds relevance to enzyme-activity assays, substrate-conversion studies, and mechanism profiling, together with downstream-response mapping in the same experimental setting. In cell signaling, inflammation, and metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Phospholipases and Lipases and related targets
• Pathway perturbation studies connected to Calcium Signaling and Metabolic Signaling
• Concentration-response inhibition and target-dependence studies
• Enzyme-activity assays, substrate-conversion studies, and mechanism profiling

Overall, (E/Z)-BML264 is appropriate when a defined chemical perturbant is needed to connect Phospholipases and Lipases and related targets with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cell signaling, inflammation, and metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.